Literature DB >> 34368928

The standardized technique and surgical video of robotic pancreaticoduodenectomy at the Chinese PLA General Hospital.

Guodong Zhao1, Qu Liu1, Zhiming Zhao1, Xiuping Zhang1, Yuanxing Gao1, Xianglong Tan1, Rong Liu2.   

Abstract

The technical complexity of robotic pancreaticoduodenectomy (RPD) and lack of technical surgical standardization have slowed its widespread application. RPD is only routinely performed in a few highly specialized centers. This study describes in detail the standard steps and core techniques of an experienced robotic center in China. We took advantage of our single experience to provide a step-by-step technique and surgical video of our RPD standardized procedure. We divided RPD into 18 key steps. Demographics and perioperative outcomes of consecutive 20 patients who underwent the RPD standardized procedure were analyzed. For the 20 consecutive patients, the mean operative time was 253.6 min, and the median estimated blood loss was 210.0 mL. One patient required conversion to laparotomy due to the need for PV reconstruction. One patient had grade 3 complication. The median postoperative hospital stay was 11.0 days. No 90-day mortality was observed. By simplifying and optimizing the surgical techniques, the RPD procedure can be standardized and modeled to improve feasibility and repeatability.
© 2021. Italian Society of Surgery (SIC).

Entities:  

Keywords:  Pancreatic surgery; Robotic pancreatoduodenectomy; Surgical technique; Uncinate process first; Whipple procedure

Mesh:

Year:  2021        PMID: 34368928     DOI: 10.1007/s13304-021-01149-6

Source DB:  PubMed          Journal:  Updates Surg        ISSN: 2038-131X


  2 in total

1.  Novel single-layer continuous suture of pancreaticojejunostomy for robotic pancreaticoduodenectomy.

Authors:  Qu Liu; Zhiming Zhao; Yuanxing Gao; Guodong Zhao; Xianglong Tan; Chihyuan Wang; Rong Liu
Journal:  J Hepatobiliary Pancreat Sci       Date:  2019-09-28       Impact factor: 7.027

2.  Comment on "Operable Pancreatic Cancer: Are We in an Era of Individualized Neoadjuvant Therapy?"

Authors:  Jie Hua; Si Shi; Xianjun Yu
Journal:  Ann Surg       Date:  2019-12       Impact factor: 12.969

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.